Ex-US Commerce Secretary Wilbur Ross pairs his SPAC with Alzheimer's biotech
Waiting until the very last minute, former US Commerce Secretary Wilbur Ross’ special purpose acquisition company has found a business to buy: a biotech allied with Biogen on diagnosing Alzheimer’s disease.
Coming together are Cambridge, MA biotech Aprinoia Therapeutics and ROSS Acquisition Corp. II, with about $280 million of ROSS stock going toward the diagnostics and drug developer. Ross will give $7.5 million of his own money through a convertible note and up to $12.5 million at the time of closing, which is expected in the first half of this year, the companies said Wednesday.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.